This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Photo Illustration of the new Wegovy semaglutide tablets with injectable prescription weight ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Lung cancer is among the conditions that may be affected. GLP-1 medications such as Wegovy, ...

GLP-1 medications offer cancer survivors a tool to manage treatment-related weight gain through coordinated care. If you've finished cancer treatment and found yourself struggling with weight changes ...

New research seems to link the use of GLP-1 (Ozempic, Wegovy, and Zepbound) with better breast cancer outcomes. Scientists don't yet know why this is — it may not be the medications themselves, but ...

“The data we're seeing on GLP-1s and cancer risk reduction is exciting, and medical oncologists are watching it closely,” says Dr. Rahul Gosain, an oncologist and co-host of The Oncology Brothers.

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the science — and culture — of weight loss. Now a growing body of research is raising ...

GLP-1 medications carry a boxed warning about the potential increased risk of thyroid cancer in some people. However, current clinical evidence also points to significant GLP-1 cancer benefits. In ...

CHICAGO—At the world’s largest oncology conference, Ozempic, a diabetes drug, found its way to the center of the conversation. As thousands of attendees bounced between presentations at the American ...

Preliminary trials suggest GLP-1 drugs may be linked with a lower risk of some cancers, especially those tied to obesity. Scientists are studying whether possible benefits come from weight loss, ...

Share on Pinterest Could GLP-1s help prevent cancer? A large study finds a link to reduced risk in several types of obesity-related cancers. Iuliia Burmistrova/Getty Images The use of GLP-1 ...

As GLP-1 medications continue reshaping the treatment of obesity and diabetes, researchers are also investigating whether the drugs could influence cancer risk and outcomes. The American Association ...